Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,378 across all filing types
Latest filing 2019-05-02 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - CSTONE AND NUMAB ANNOUNCE EXCLUSIVE REGIONAL LICENSING AGREEMENT FOR ND021, A MULTI-FUNCTIONAL DRUG CANDIDATE AND POTENTIAL NEXT-GENERATION IMMUNOTHERAPY
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals about entering into an exclusive regional licensing agreement with Numab Therapeutics for a drug candidate ND021. It describes the terms of the licensing agreement, the drug's characteristics, and company background. There are no financial statements, no regulatory certifications, no voting results, no management or board changes, no earnings data, and no detailed financial or operational report. The document is an announcement of a business collaboration/licensing deal, which fits best under Capital/Financing Update (CAP) as it relates to a strategic licensing agreement impacting the company's development pipeline and potential commercialization rights. The document length (7598 characters) and content confirm it is not a brief report publication announcement or a regulatory filing. Therefore, the classification is CAP with high confidence.
2019-05-02 English
2018 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is titled '2018 Annual Report' and contains detailed sections typical of an annual report, including corporate information, financial highlights, chairman's statement, management discussion and analysis, directors and senior management, corporate governance report, independent auditor's report, and consolidated financial statements. The content includes comprehensive financial data for the year ended December 31, 2018, and detailed narrative on business review and clinical development strategy. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is merely an announcement of a report or a certification document. Therefore, this document fits the definition of an Annual Report (10-K). FY 2018
2019-04-29 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2019-04-29 English
RESULTS REPORT FOR THE FIRST QUARTER OF 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'RESULTS REPORT FOR THE FIRST QUARTER OF 2019' and contains detailed financial data for the first quarter ending 31 March 2019. It includes unaudited financial statements, operating income, net profit, earnings per share, and other financial indicators. The report references compliance with the China Securities Regulatory Commission (CSRC) regulations for quarterly reports and accounting standards. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-26 English
Notification Letter
Report Publication Announcement Classification · 95% confidence The document is a notification letter from Yanzhou Coal Mining Company Limited dated 26 April 2019. It informs shareholders about the publication of a supplementary notice and revised form of proxy for the 2018 Annual General Meeting (AGM). The letter provides instructions on how shareholders can access these corporate communications, including the directors' report, annual accounts, auditors' report, interim reports, notices of meetings, circulars, and proxy forms. It also includes a change request form for shareholders to select their preferred language and means of receiving future corporate communications. The document does not contain any financial statements, detailed financial analysis, or management discussion. It is primarily an announcement regarding the availability and distribution of corporate communications related to the AGM, not the AGM materials themselves. The document length is 9071 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than an Annual Report (10-K) or AGM Information (AGM-R).
2019-04-26 English
Revised Form of Proxy for Use at the Annual General Meeting
AGM Information Classification · 95% confidence The document is a proxy form for the Annual General Meeting (AGM) of Yanzhou Coal Mining Company Limited for the year ended 31 December 2018. It includes detailed instructions for shareholders to appoint proxies to vote on various resolutions at the AGM, including approval of the board's working report, audited financial statements, profit distribution, director appointments, and other corporate matters. The document is not the AGM report or minutes itself but a form used to facilitate voting at the AGM. It is directly related to the AGM process and contains proxy voting instructions and resolutions to be voted on at the AGM. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms.
2019-04-26 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.